Omzar (Esomeprazole Magnesium Dihydrate)

Esomeprazole Magnesium Dihydrate, the active ingredient in Omzar, is a proton pump inhibitor (PPI) presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and adolescents. GNH USA supplies Omzar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omzar is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to esomeprazole may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Liver enzyme elevation: signs of hepatic dysfunction. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Omzar, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: prolonged therapy can cause hypomagnesemia. - Evaluate fracture risk: long‑term use may affect bone density. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C, retain in original packaging and protect from moisture.

Esomeprazole may interact with several medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular event risk. - Atazanavir and other protease inhibitors: markedly decreased antiviral exposure. - Methotrexate (high dose): increased serum concentrations, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Digoxin: higher serum levels may occur, check therapeutic range. - Diazepam: increased sedation, adjust dose if necessary.